Abbott
ABT
$0.75 (0.57%)
1D
1W
3M
1Y
5Y
ALL
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 2 days ago • ABT
Abbott Labs' Rally Is Well Deserved - Fade The Rally For NowBenzinga • 4 days ago • ABT
These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected EarningsMarketBeat • 4 days ago • ABT
Tariff-Resistant Abbott Laboratories on Track for New HighsSeeking Alpha • 5 days ago • ABT
Abbott Q1: Flexible Supply Chain And Strong Growth In Medical DevicesSeeking Alpha • 5 days ago • ABT
Abbott Laboratories (ABT) Q1 2025 Earnings Call TranscriptCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.